Serzone
Do not discontinue taking any medications without first consulting your physician.
Serzone® or nefazodone, was approved for use as an antidepressant for patients
with severe depression and anxiety. The chemically unique formula of Serzone®
was considered a pharmaceutical breakthrough, because it effectively balanced depression-causing
chemicals in the brain while minimizing the typical side effects of antidepressants,
which include weight gain, sleep deprivation, and decreased libido.
After its release, Serzone® was linked to a 300% increased risk of liver transplant
or death for users. Due to this extremely elevated risk of liver toxicity, the FDA
ordered Serzone®’s manufacturer, Bristol-Myers Squibb, Co. to add a black
box warning to Serzone®’s label. The new label outlined the drug’s
potentially deadly side effects. In June 2004, Bristol-Myers Squibb, Co. voluntarily
withdrew the drug from the market.
Serzone® may cause irreversible damage to the liver. Symptoms of this damage
include the following:
- Abdominal pain
- Yellowing of skin or eyes
- Nausea
- Dark urine
- Abdominal sweating
- Loss of appetite
If you or a loved one used Serzone® to treat depression, contact a John Bales
Florida drug injuries lawyer. Complete a FREE Online Consultation Form
or call us toll free 1-800-CALL JOHN (1-800-225-5564) 24 hours,
7 days a week.
Do not discontinue taking any medications without first consulting your physician.
This article is for informational purposes only. It is not intended to constitute
medical advice and should not be viewed as such. For medical advice, you should
always consult with your physician.
Serzone® is a registered trademark of Bristol-Myers Squibb, Co. The reference
to the registered trademarks of Bristol-Myers Squibb, Co. is used here only for
the purpose of identifying the product in question.
This law firm is not affiliated with, sponsored by, or associated with Bristol-Myers
Squibb, Co. or the FDA.